Beta2-microglobulin mutations in microsatellite unstable colorectal tumors

International Journal of Cancer

Volumn 121, Issue 2, 2007, Pages 454-458

  Kloor, Matthias ^a   Michel, Sara ^a   Buckowitz, Boris ^a   Rüschoff, Josef ^b   Büttner, Reinhard ^c   Holinski Feder, Elke ^d   Dippold, Wolfgang ^e   Wagner, Rudolf ^f   Tariverdian, Mirjam ^a   Benner, Axel ^g   Schwitalle, Yvette ^a   Kuchenbuch, Beate ^a   Doeberitz, Magnus Von Knebel ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KLINIKUM KASSEL   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e St Vinzenz und Elizabeth Hospital   (Germany)

^f Westpfalz Klinikum GmbH   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Colorectal adenoma; Colorectal cancer; Hereditary nonpolyposis colorectal cancer; Immune selection; Microsatellite instability; Tumor immune evasion

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; LYMPHOCYTIC INFILTRATION; MALE; METASTASIS; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BETA 2-MICROGLOBULIN; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASM STAGING; NUCLEAR PROTEINS;

EID: 34250349133     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22691     Document Type: Article

References (25)

1. Ionov Y, Peinado MA, Malkbosyan S, Shibata D, Perucho M, Ubiquitous somatic mutations in simple repealed sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
2. Umar A, Risinger JI, Hawk ET, Barren JC. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004;4:153-8.
3. Boland CR, Tbibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ., Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
4. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D. et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:1851-60.
5. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005;23:609-18.
6. Buckowitz A, Knaebel HP, Benner A, Blaker H, Gebert J, Kienle P, von Knebet Doeberitz M, Kloor M. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer 2005;92:1746.
7. Banerjea A, Bustin SA, Dorudi S. The immunogenicity of colorectal cancers with high-degree microsatellite instability. World J Surg Oncol 2005;3:267
8. Linnebacher M, Gebert J, Rudy W, Woerner S, Yuan YP, Bork P, von Knebel Doeberitz M. Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens. Int J Cancer 2001;93:6-11.
9. Saetertdal I, Bjorheim J, Lislerud K, Giertsen MK, Bukholm IK, Olsen OC, Nesland JM, Eriksen JA, Moller M, Lindblom A, Gaudernack G. Frameshift-mutation- derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 2001;98:13255-60.
10. Dolceiti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, Vecchiato N, Macri E, Fornasarig M, Boiocchi M. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 1999;154:1805-13.
11. Shia J, Ellis NA, Paty PB, Nash GM, Qin J, Offit K, Zhang XM, Markowitz AJ, Nala K, Guillem JG, Wong WD, Gerald WL. et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 2003;27:1407-17.
12. Kloor M, Becker C, Benner A, Woerner SM, Gebert J, Ferrone S, von Knebel Doeberitz M. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res 2005;65:6418-24.
13. Bicknell DC, Kaklamanis L, Hampson R, Bodmer WF, Karran P. Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol 1996;6:1695-7.
14. Cabrera CM, Jimenez P, Cabrera T, Esparza C, Ruiz-Cabello F, Garrido F. Total loss of MHC class 1 in colorectal tumors can be explained by two molecular pathways: β2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors. Tissue Antigens 2003;61:211-9.
15. Findeisen P, Kloor M, Merx S, Sutler C, Woerner SM, Dostmann N, Benner A, Dondog B, Pawlita M, Dippold W, Wagner R, Gebert J, et al. T25 repeat in the 3′ untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 2005;65:8072-8.
16. American Joint Committee on Cancer. AJCC cancer staging manual. 5th edn. Philadelphia: Lippincott-Raven. 1997.
17. Mangold E, Pagenstecher C, Friedl W, Mathiak M, Buettner R, Engel C, Loeffler M, Holinski-Feder E, Muller-Koch Y, Keller G, Sehackert HK, Kruger S. et al. Spectrum and frequencies of initiations in MSH2 and MLH1 identified in 1.721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 2005;116:692-702.
18. Lampson LA, Fisher CA, Whelan JP. Striking paucity of HLA-A. B. C and β2-microglobulin on human neuroblastoma cell lines. J Immunol 1983;130:2471-8.
19. Clarkson DB, Fan Y-A, Joe H. A remark on algorithm 643: FEXACT: an algorithm for performing Fisher's exact test in rxc contingency tables. ACM Trans Math Software 1993;19:484-8.
20. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med 2002;21:2409-19.
21. Yamamoto H, Yamashita K, Perucho M. Somatic mutation of the β-microglobulin gene associates with unfavorable prognosis in gastrointestinal cancer of the microsatellite mutator phenotype. Gastroenterology 2001;120:1565-7.
22. Parsons R, Myeroff LL, Liu B., Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
23. Woerner SM, Kloor M, Mueller A, Rueschoff J, Friedrichs N, Buettner R, Buzello M, Kienle P, Knaebel HP, Kunstmann E, Pagenstecher C, Schackert HK, et al. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene 2005;24:2525-35
24. Menon AG, Tollenaar RA, van de Velde CJ, Putter H, Janssen-van Rhijn CM, Keijzer R, Fleuren GJ, Kuppen PJ. p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases. Clin Exp Metastasis 2004;21:79-85.
25. Watson NF, Ramage JM, Madjd Z, Spendlove I, Ellis IO, Scholefield JH, Durrant LG. Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int J Cancer 2006;118:6-10.